Russell Scammell

Senior Director, Small Molecule Drug Discovery at Charles River

Home
Ask-the-experts
Russell Scammell - Senior Director, Small Molecule Drug Discovery at Charles River

About

Russell Scammell is currently a Senior Director within small molecule drug discovery at Charles River.

He has worked in the pharmaceutical industry for over 35 years at all stages of research and development where he has led the Pharmaceutics, Formulation, Chemistry and Analytical sciences groups at Aventis, Argenta Discovery and Charles River. Russell joined Charles River in 2014 and his primary role has been providing industry leading delivery of small molecule drug discovery pharmaceutical sciences and preclinical development expertise.

Expertise & focus areas

Quotient Sciences Translational Pharmaceutics

Translational Pharmaceutics, Drug Product Optimization, First-in-Human, Human ADME

Translational Pharmaceutics® Integrated Drug Development Info Sheet

10 March 2025 Read More

Latest news from Quotient Sciences

More News

News & Announcements, Articles & Publications, Translational Pharmaceutics®, Dr. Asma Patel, Matt Paterson Dr. Asma Patel and Matt Paterson contribute to Drug Development & Delivery's special feature, 'Outsourcing Formulation Development & Manufacturing' By: Dr. Asma Patel and Matt Paterson

News & Announcements, Articles & Publications, commercial manufacturing, Dr. Helen Baker, Dr. Richard Castledine Dr. Helen Baker and Dr. Richard Castledine contribute to Pharmaceutical Technology's 'Poor API Quality Threatens a Healthy Supply' By: Dr. Helen Baker and Dr. Richard Castledine

News & Announcements, Articles & Publications, Thierry Van Nieuwenhove Thierry Van Nieuwenhove on the Future of CDMO Partnerships By: Thierry Van Nieuwenhove

More News